Trial description:
A Phase 3, randomized, open-label study of NKTR-214 combined with nivolumab versus nivolumab alone in participants with previously untreated unresectable or metastatic melanoma
Contact name:
Dr Pippa Corrie
Trial start date:
Tuesday, July 30, 2019
Trial end date:
Monday, August 31, 2020
Trial tumour type:
Skin & melanoma
Show on Radiotherapy:
No
